Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment

By: via Benzinga
Organon & Co(NYSE: OGN)will license global rightstoDarBioscience Inc's(NASDAQ: DARE) ...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.